Cannula provoked upper extremity superficial vein thrombophlebitis: are we overtreating?

Intern Med J. 2022 Nov;52(11):1995-1997. doi: 10.1111/imj.15951. Epub 2022 Nov 3.

Abstract

Cannula provoked upper extremity superficial vein thrombophlebitis (UESVT) is common. Retrospective audit of 93 consecutive patients, 51% male, median age 57 years (range 20-91), with symptomatic UESVT revealed varied management including symptomatic management (37%), prophylactic (37%) and higher dose anticoagulation (27%). There was 2% (95% confidence interval (CI) 0-7.6) thrombus extension and 1% (95% CI 0-5.9) major bleeding, both limited to cancer. We argue anticoagulation is unnecessary in most UESVT patients.

Keywords: cannula; thrombophlebitis; venous thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects
  • Cannula*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Thrombophlebitis* / etiology
  • Upper Extremity
  • Young Adult

Substances

  • Anticoagulants